Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient

Abstract

Progressive multifocal leukoencephalopathy (PML) associated with polyomavirus JC (JCV) infection has been reported to be usually fatal in allogeneic hematopoietic SCT (HSCT) recipients. We present the case of a 19-year-old HSCT patient diagnosed with JCV-associated PML after prolonged immunosuppression for severe GVHD. No short-term neurological improvement was observed after antiviral treatment and discontinuation of immunosuppressive therapy. Donor-derived JCV Ag-specific CTLs were generated in vitro after stimulation with 15-mer peptides derived from VP1 and large T viral proteins. After adoptive CTL infusion, virus-specific cytotoxic cells were shown in the peripheral blood, JCV-DNA was cleared in the cerebrospinal fluid and the patient showed remarkable improvement. Adoptive T-lymphocyte therapy with JCV-specific CTLs was feasible and had no side effects. This case suggests that adoptive transfer of JCV-targeted CTLs may contribute to restore JCV-specific immune competence and control PML in transplanted patients.

DOI: 10.1038/bmt.2010.221
050010001500200920102011201220132014201520162017
Citations per Year

2,209 Citations

Semantic Scholar estimates that this publication has 2,209 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Balduzzi2011PolyomavirusJT, title={Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient}, author={Adriana Balduzzi and Giuseppe Lucchini and H . H . Hirsch and Sabrina Basso and Michela Cioni and Attilio M Rovelli and Alessandra Zincone and M Grimaldi and Paola Corti and Sonia Bonanomi and A Biondi and Francesco Locatelli and Ettore Biagi and Patrizia Comoli}, journal={Bone Marrow Transplantation}, year={2011}, volume={46}, pages={987-992} }